知镜 Cognispect · 医学文献与研究工作台

Skin-resident CXCR6 + memory CD4 + T cells and dendritic cells form dermal perivascular hubs that drive relapse in allergic dermatitis.

Asahina R, Minami F, Nakamizo S, Miyake T, Yonekura S, Kogame T, Kanameishi S, Katsuo K, Irie H, Nakajima S, Nomura T, Kitoh A, Egawa G, Kabashima K.
Immunity · 2026-10-12 · PMID 42863468

文献摘要

CD4 + tissue-resident memory T (T RM ) cells are crucial for relapse in allergic skin conditions. However, the mechanisms underlying their maintenance and pathogenic potential remain poorly defined. Here, across multiple models of allergic dermatitis, we identified a C-X-C chemokine receptor 6 (CXCR6 + ) subpopulation within CD4 + T RM cells as a distinct pathogenic subset that rapidly induces relapse. This subset is supported by C-X-C chemokine ligand 16 (CXCL16)-dependent interactions with CD301b + conventional type 2 dendritic cells (cDC2s) for in situ maintenance. Functional blockade of the CXCL16-CXCR6 signaling pathway impaired proliferation and maintenance of CXCR6 + CD4 + T RM cells. In human atopic dermatitis (AD), CXCR6 + CD4 + T RM cells co-localized with CD301 + cDC2s in perivascular clusters even after successful anti-IL-13 therapy. These findings point to CXCR6 + CD4 + T RM cells as a pathogenic reservoir sustaining chronic and recurrent inflammation and suggest the CXCL16-CXCR6 axis as a therapeutic target to prevent relapse in allergic skin diseases.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。